| Literature DB >> 27809764 |
Christopher S Nelson1, Jennifer N Beck1,2, Kenneth A Wilson1,3, Elijah R Pilcher1, Pankaj Kapahi4,5,6, Rachel B Brem7,8,9.
Abstract
BACKGROUND: Obesity-related diseases are major contributors to morbidity and mortality in the developed world. Molecular diagnostics and targets of therapies to combat nutritional imbalance are urgently needed in the clinic. Invertebrate animals have been a cornerstone of basic research efforts to dissect the genetics of metabolism and nutrient response. We set out to use fruit flies reared on restricted and nutrient-rich diets to identify genes associated with starvation resistance, body mass and composition, in a survey of genetic variation across the Drosophila Genetic Reference Panel (DGRP).Entities:
Keywords: Dietary restriction; Drosophila; GWAS; Nutrition; Obesity
Mesh:
Substances:
Year: 2016 PMID: 27809764 PMCID: PMC5095962 DOI: 10.1186/s12864-016-3137-9
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Variants associated with metabolic traits
| Screena | Phenotype(s)b | Testb | Chrc | Positionc | Genec | % Vard |
| FDRf |
|---|---|---|---|---|---|---|---|---|
| MAF ≥ 5 % | starvation resistance | genotype | 2L | 13967604 |
| 18 % | 3.70E-13 | 0 % |
| MAF ≥ 5 % | triglycerides | genotype | 3R | 14072066 |
| 20 % | 1.29E-14 | 10 % |
| MAF ≥ 5 % | starvation resistance and triglycerides on AL | SMAT | 3L | 11418293 |
| 8 % | 8.88E-16 | 0 % |
| MAF ≥ 5 % | starvation resistance and triglycerides on AL | SMAT | 2R | 16952034 |
| 6 % | 6.18E-11 | 10 % |
| MAF ≥ 5 % | starvation resistance and mass on AL | SMAT | 3R | 19635620 |
| 8 % | 1.71E-13 | 10 % |
| MAF ≥ 5 % | starvation resistance and mass on AL | SMAT | 3R | 24549344 |
| 12 % | 2.78E-12 | 10 % |
| MAF ≥ 5 % | starvation resistance and mass on DR | SMAT | X | 6152605 |
| 3 % | 4.44E-16 | 0 % |
| MAF ≥ 5 % | starvation resistance and mass on DR | SMAT | X | 6152619 |
| 3 % | 4.44E-16 | 0 % |
| MAF ≥ 5 % | starvation resistance and mass on DR | SMAT | X | 6152558 |
| 2 % | 6.66E-16 | 0 % |
| MAF ≥ 5 % | starvation resistance and mass on DR | SMAT | X | 6152586 |
| 2 % | 8.88E-16 | 0 % |
| MAF ≥ 25 % | body mass | genotype | X | 12430723 |
| 15 % | 3.84E-13 | 0 % |
| MAF ≥ 25 % | glucose | interaction | 3R | 8877613 |
| 4 % | 5.94E-3 | 7 % |
| MAF ≥ 25 % | glucose | interaction | 3R | 8877592 |
| 4 % | 6.72E-3 | 7 % |
| MAF ≥ 25 % | glucose | interaction | 3R | 8877227 |
| 5 % | 6.75E-3 | 7 % |
| MAF ≥ 25 % | glucose | interaction | 3R | 8877378 |
| 5 % | 8.69E-3 | 8 % |
| MAF ≥ 25 % | starvation | genotype | 2L | 13967604 |
| 18 % | 3.70E-13 | 0 % |
| MAF ≥ 25 % | starvation resistance and mass on DR | SMAT | X | 8903670 |
| 15 % | 1.27E-08 | 10 % |
| MAF ≥ 25 % | starvation resistance and triglycerides on DR | SMAT | 3R | 4279209 |
| 8 % | 1.29E-09 | 10 % |
aResults from association scans across markers meeting the indicated criterion. For results from the scaled multiple-phenotype association test (SMAT) applied to variants at frequency of ≥5 %, only human disease orthologs were tested
bThe single phenotype whose measurements in animals reared on both diets were tested in a linear model with terms for diet, genotype, and the interaction between the two; or the pair of phenotypes whose measurements in animals reared on the indicated diet were tested via SMAT. DR, dietary restriction; AL, ad libitum
cChromosome segment, position (in D. melanogaster genome version R5 coordinates), and gene in which the associating marker lay
dPercent phenotypic variation explained by the indicated polymorphism. For pairs of phenotypes, the value reports results for the single phenotype with the highest % variance explained
eNominal association p-value
fFalse discovery rate at the association p-value according to permutation analysis
Fig. 1The ceramide synthase schlank governs body mass, starvation, and lifespan. a and b Trait association to schlank genotype in the DGRP. In a given panel, each point reports phenotype measurements (y-axis) from one DGRP strain homozygous for the schlank allele indicated on the x-axis. Each black horizontal bar reports the mean phenotype across all strains harboring the indicated allele. c-e Validation of schlank function. c Each trace reports survival of a strain harboring a schlank RNAi construct and a GAL4-GeneSwitch (GS) activator under the daughterless promoter, pre-treated with RU486 (+ drug, dotted lines) or vehicle (no drug, solid lines) for 10 days on the indicated diet and then switched to acute starvation media. d Each column reports body mass per fly of the indicated strain, with genotypes as in c (n = 2 populations of 15 flies per condition). e Each column reports whole body triglyceride levels per fly of the indicated strain, with genotypes as in c (n = 1 population of 15 flies per condition). For d and e top, middle, and bottom horizontal bars of a given vertical box denote the respective quartiles over batches and/or technical replicates, and the top and bottom short horizontal bars report minimum and maximum, respectively. AL, ad libitum diet; DR, dietary restriction. *, p < 0.05, **, p < 0.01, ***, p < 10-3, ****, p <10-7, *****, p < 10-15. Red asterisks denote significance of the effect of the genetic perturbation in animals on AL food, blue denotes significance in animals on DR food, and purple denotes significance of the interaction between diet and genetic perturbation. For strain details see Additional file 1: Table S6
Fig. 2A metabolic function for fly huntingtin (htt). a and b Trait association to htt genotype in the DGRP. Data are as in Fig. 1a-b, except that an intronic indel in htt is analyzed. c and d Validation of htt function in laboratory strains. c Each trace reports survival of a strain expressing a GAL4 activator under the daughterless promoter and harboring an htt RNAi construct (RNAi) or no RNAi transgene (control), pre-treated for 10 days on the indicated diet and then switched to acute starvation media. d Each column reports body mass per fly of the indicated strain, with genotypes as in c. (n = 5 populations of 15 flies per condition). Symbols and abbreviations are as in Fig. 1. For strain details see Additional file 1: Table S6
Fig. 3CG43921/heavyweight is a novel determinant of body mass. a DGRP trait association with heavyweight (hwt) genotype. Data are as in Fig. 1a-b except that an intronic variant in hwt is analyzed. b Validation of hwt function in laboratory strains. Each column reports body mass per fly of a strain expressing a GAL4 activator under the daughterless promoter and harboring an hwt RNAi construct (RNAi) or no RNAi transgene (control) (n = 2 populations of 15 flies per condition). Symbols and abbreviations are as in Fig. 1. For strain details see Additional file 1: Table S6
Fig. 4The diacylglycerol kinase rdgA governs body mass, starvation resistance, and lifespan. a and b Trait association to rdgA genotype in the DGRP. Data are as in Fig. 1a-b, except that an intronic variant in rdgA is analyzed. c-e Validation of rdgA function in laboratory strains. c Each trace reports survival of a strain harboring a transposon insertion in rdgA (mutant) or isogenic wild-type control, pre-treated for 10 days on the indicated diet and then switched to acute starvation media. d Each column reports body mass per fly of the indicated strain, with genotypes as in c (n = 2 populations of 15 flies per condition). e Each column reports whole body triglyceride levels normalized to body mass in the indicated strain, with genotypes as in c (n = 1 population of 15 flies per condition). Symbols and abbreviations are as in Fig. 1. For strain details see Additional file 1: Table S6